New York State Common Retirement Fund Oncorus, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.04 - $1.86 $12,604 - $22,543	-12,120 Reduced 98.35%	203 $0
Q1 2022 May 05, 2022	SELL	$1.44 - $5.62 $161 - $629	-112 Reduced 0.9%	12,323 $22,000
Q4 2021 Feb 02, 2022	BUY	$5.03 - $11.63 $553 - $1,279	110 Added 0.89%	12,435 $66,000
Q3 2021 Nov 02, 2021	SELL	$9.29 - $14.27 $48,633 - $74,703	-5,235 Reduced 29.81%	12,325 $115,000
Q2 2021 Aug 02, 2021	BUY	$13.3 - $17.3 $136,458 - $177,498	10,260 Added 140.55%	17,560 $242,000
Q1 2021 May 11, 2021	BUY	$11.89 - $35.55 $41,615 - $124,424	3,500 Added 92.11%	7,300 $102,000
Q4 2020 Feb 08, 2021	BUY	$15.0 - $35.15 $57,000 - $133,570	3,800 New	3,800 $123,000

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.